Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review
Anthony Vignone, Francesca Biancaniello, Marco Casadio, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 21, pp. 4901-4901
Open Access | Times Cited: 10

Showing 10 citing articles:

Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging
Jiong Liu, Jian Shu
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104235-104235
Closed Access | Times Cited: 5
Role of the Gut–Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence
Maria Consiglia Bragazzi, Rosanna Venere, Anthony Vignone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6660-6660
Open Access | Times Cited: 9
L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression
Biqiang Zhu, Jingjing Zheng, Gaichao Hong, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 4
Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment
Fei Pei, Tao Zhen, Lu Qi, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Biliary Adenofibroma: A Rare Liver Tumor with Transition to Invasive Carcinoma
Ayham Alshbib, Krzysztof Grzyb, Trygve Syversveen, et al.
Case Reports in Surgery (2022) Vol. 2022, pp. 1-5
Open Access | Times Cited: 6
Comparison of Different First-Line Systemic Therapies in Advanced Biliary Tract Cancer Based on Updated Random Controlled Trials: A Systematic Review and Network Meta-Analysis
Long Feng, Ying Wang, Haoqian Xu, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 4
Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinoma
Qin Liu, Yuanyuan Chen, Yan Hu, et al.
Cancer Treatment and Research Communications (2023) Vol. 37, pp. 100771-100771
Open Access | Times Cited: 2
Special Issue “New Therapies of Liver Diseases”
Pierluigi Toniutto
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 1798-1798
Open Access | Times Cited: 3
Men's gallbladder cancer: epidemiology, prevention, and treatment strategies

Journal of Men s Health (2024) Vol. 20, Iss. 7, pp. 1-1
Open Access
Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023)
Xi-lin Qu, Qian Wang, Fengfeng Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1

Scroll to top